Tianjin Meihua Biotechnology

Tianjin Meihua Biomedical Technology is a pharmaceutical company based in Tianjin, China, specializing in the development and manufacture of respiratory inhalation preparations. Founded in 1981, the company has established a strong presence in the respiratory market with a portfolio of aerosols and inhalation solutions, including salbutamol sulfate, beclometasone dipropionate, and ipratropium bromide. Marketed under brands such as Tan Zhi Shu and Pu Li Chang, its products are used to treat chronic conditions like asthma and chronic obstructive pulmonary disease (COPD). The company operates a full-chain business model, supported by its R&D subsidiary, Tianjin Mingtai Pharmaceutical Technology, and maintains GMP-certified manufacturing facilities. It also produces other pharmaceutical formulations, including controlled-release capsules and antiviral medications.